Source: https://www.hankyung.com/it/article/202109065727i
120억원 투자 받은 파이안바이오, 미토콘드리아 신약 임상 계획 승인
Source: https://biz.chosun.com/stock/stock_general/2021/06/17/Y2ICBHE75RHZTN3XCFO3LXGUVE/
Read more
IND Approval for PN-101 by MFDS
PAEAN Biotechnology, a company specializing in the development of new mitochondrial drugs, announced today that the Ministry of Food and Drug Safety (MFDS) has approved the Investigational New Drug
Read more